A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it cannot proceed.

The number of deaths, injuries and missing is approaching a grim milestone after nearly four years of fighting.

In fact, almost 9 in 10 Gen Z (89 percent) and Millennial (88 percent) survey respondents who said they will travel in 2026 ...

Malaysia’s government plans to do a cost-benefit analysis of its controversial trade agreement with the US, while warning ...

Finding the right laptop in 2026 means balancing performance, portability, and affordability. The latest models deliver ...

A brief, calorie-restricted diet centered almost entirely on oats led to a surprisingly strong and lasting reduction in cholesterol in people with metabolic syndrome. A very short dietary intervention ...

CalciMedica’s stock nosedived after the biotech abandoned a phase 2 study of its calcium release-activated calcium (CRAC) ...

An ethics plan released Tuesday was the first detailed policy proposal from Republican candidate for governor John James.

Guinea-Bissau's health minister says the government is suspending a Trump administration-backed hepatitis B vaccine study on ...

Plans for a controversial U.S.-funded hepatitis B vaccine study in Guinea-Bissau have been paused pending further review from national authorities.

New York stands to lose two seats in Congress after the 2030 census with the blue state's population growth lagging far ...

Explore St. Louis will pay the estimated $125,000 cost of the study using money from hotel-motel taxes in St. Louis County, a ...